{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T08:05:04Z","timestamp":1784016304690,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"Taiwan Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.nano.2026.102983","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T16:19:24Z","timestamp":1782231564000},"page":"102983","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["PEGylation-associated hemodynamic effects in a rodent model of acute hypersensitivity reaction: Complement activation-mediated mechanisms"],"prefix":"10.1016","volume":"75","author":[{"given":"Sin-Ting","family":"Ngo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Tsung","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jau-Song","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-Yi","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsi-Mei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0481-1180","authenticated-orcid":false,"given":"Yunn-Hwa","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2026.102983_bb0005","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.addr.2020.07.024","article-title":"Anti-PEG antibodies: properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals","volume":"154-155","author":"Kozma","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"10.1016\/j.nano.2026.102983_bb0010","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.nano.2026.102983_bb0015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jconrel.2022.09.031","article-title":"Polyethylene glycol (PEG): The nature, immunogenicity, and role in the hypersensitivity of PEGylated products","volume":"351","author":"Ibrahim","year":"2022","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.nano.2026.102983_bb0020","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2025.2494775","article-title":"PEGylation technology: addressing concerns, moving forward","volume":"32","author":"Simberg","year":"2025","journal-title":"Drug Deliv"},{"key":"10.1016\/j.nano.2026.102983_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114079","article-title":"To PEGylate or not to PEGylate: immunological properties of nanomedicine\u2019s most popular component, polyethylene glycol and its alternatives","volume":"180","author":"Shi","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"issue":"9","key":"10.1016\/j.nano.2026.102983_bb0030","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1093\/annonc\/mdg374","article-title":"Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil\u00ae): possible role in hypersensitivity reactions","volume":"14","author":"Chanan-Khan","year":"2003","journal-title":"Ann Oncol"},{"issue":"1\u20132","key":"10.1016\/j.nano.2026.102983_bb0035","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000479878","article-title":"Drug-induced pseudoallergy: a review of the causes and mechanisms","volume":"101","author":"Zhang","year":"2018","journal-title":"Pharmacology"},{"key":"10.1016\/j.nano.2026.102983_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2019.00414","article-title":"Cytotoxicity-related bioeffects induced by nanoparticles: the role of surface chemistry","volume":"7","author":"Sun","year":"2019","journal-title":"Front Bioeng Biotechnol"},{"issue":"4","key":"10.1016\/j.nano.2026.102983_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8040082","article-title":"Human clinical relevance of the porcine model of pseudoallergic infusion reactions","volume":"8","author":"Szebeni","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.nano.2026.102983_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10061260","article-title":"Immediate hypersensitivity reactions induced by COVID-19 vaccines: current trends, potential mechanisms and prevention strategies","volume":"10","author":"Hung","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.nano.2026.102983_bb0055","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jconrel.2019.07.005","article-title":"Liposome-induced hypersensitivity reactions: Risk reduction by design of safe infusion protocols in pigs","volume":"309","author":"F\u00fcl\u00f6p","year":"2019","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2026.102983_bb0060","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2014.08.009","article-title":"Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: Comparison of the porcine and rat responses","volume":"195","author":"D\u00e9zsi","year":"2014","journal-title":"J Control Release"},{"issue":"17","key":"10.1016\/j.nano.2026.102983_bb0065","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1161\/01.CIR.99.17.2302","article-title":"Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: a model for pseudoallergic cardiopulmonary reactions to liposomes: role of complement and inhibition by soluble CR1 and anti-C5a antibody","volume":"99","author":"Szebeni","year":"1999","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.nano.2026.102983_bb0070","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1161\/01.RES.66.4.1103","article-title":"Role of thromboxane A2 in the cardiovascular response to intracoronary C5a","volume":"66","author":"Stahl","year":"1990","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.nano.2026.102983_bb0075","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3109\/10731199709118925","article-title":"Complement activation and thromboxane secretion by liposome-encapsulated hemoglobin in rats in vivo: inhibition by soluble complement receptor type 1","volume":"25","author":"Szebeni","year":"1997","journal-title":"Artif Cells Blood Substit Immobil Biotechnol"},{"issue":"15","key":"10.1016\/j.nano.2026.102983_bb0080","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1039\/D0AN00633E","article-title":"Engineering at the nano-bio interface: harnessing the protein corona towards nanoparticle design and function","volume":"145","author":"Pinals","year":"2020","journal-title":"Analyst"},{"key":"10.1016\/j.nano.2026.102983_bb0085","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.2147\/IJN.S192214","article-title":"Plasma protein adsorption on Fe3O4-PEG nanoparticles activates the complement system and induces an inflammatory response","volume":"14","author":"Escamilla-Rivera","year":"2019","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2026.102983_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114356","article-title":"The effects of protein corona on in vivo fate of nanocarriers","volume":"186","author":"Xiao","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"10.1016\/j.nano.2026.102983_bb0095","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1039\/D2LC00799A","article-title":"Nanoparticle protein corona: from structure and function to therapeutic targeting","volume":"23","author":"Bashiri","year":"2023","journal-title":"Lab Chip"},{"issue":"13","key":"10.1016\/j.nano.2026.102983_bb0100","doi-asserted-by":"crossref","first-page":"12458","DOI":"10.1021\/acsnano.3c02041","article-title":"Identification of the proteins determining the blood circulation time of nanoparticles","volume":"17","author":"Marques","year":"2023","journal-title":"ACS Nano"},{"issue":"18","key":"10.1016\/j.nano.2026.102983_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24183283","article-title":"Complement activation-related pathophysiological changes in anesthetized rats: activator-dependent variations of symptoms and mediators of pseudoallergy","volume":"24","author":"Dezsi","year":"2019","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.nano.2026.102983_bb0110","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1021\/acs.nanolett.0c00432","article-title":"The Future in Nanosafety","volume":"20","author":"Shatkin","year":"2020","journal-title":"Nano Lett"},{"issue":"9-10","key":"10.1016\/j.nano.2026.102983_bb0115","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/17435390.2022.2154176","article-title":"Iron oxide nanoparticles cause surface coating- and core chemistry-dependent endothelial cell ferroptosis","volume":"16","author":"Zhang","year":"2022","journal-title":"Nanotoxicology"},{"issue":"12","key":"10.1016\/j.nano.2026.102983_bb0120","doi-asserted-by":"crossref","first-page":"8522","DOI":"10.1021\/acs.biomac.5c01369","article-title":"PEGylation-driven remodeling of the protein corona on PLGA nanoparticles: implications for macrophage recognition","volume":"26","author":"Spinelli","year":"2025","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.nano.2026.102983_bb0125","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.addr.2019.01.005","article-title":"Iron oxide nanoparticles: diagnostic, therapeutic and theranostic applications","volume":"138","author":"Dadfar","year":"2019","journal-title":"Adv Drug Deliv Rev"},{"issue":"7","key":"10.1016\/j.nano.2026.102983_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13070943","article-title":"Magnetic nanoparticles in biology and medicine: past, present, and future trends","volume":"13","author":"Stueber","year":"2021","journal-title":"Pharmaceutics"},{"issue":"18","key":"10.1016\/j.nano.2026.102983_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24183407","article-title":"Targeted delivery of plasminogen activators for thrombolytic therapy: an integrative evaluation","volume":"24","author":"Ma","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.nano.2026.102983_bb0140","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.2147\/IJN.S204844","article-title":"Effects of PEGylation on capture of dextran-coated magnetic nanoparticles in microcirculation","volume":"14","author":"Chiu","year":"2019","journal-title":"Int J Nanomedicine"},{"issue":"4","key":"10.1016\/j.nano.2026.102983_bb0145","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/00005344-199604000-00005","article-title":"Validation of transonic small animal flowmeter for measurement of cardiac output and regional blood flow in the rat","volume":"27","author":"Wen","year":"1996","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"10.1016\/j.nano.2026.102983_bb0150","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1160\/TH17-05-0330","article-title":"Passivating injured endothelium with kinexins in thrombolytic therapy","volume":"118","author":"Ma","year":"2018","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.nano.2026.102983_bb0155","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1309\/AJCPXPD7ZQXNTIAL","article-title":"Effect of blood sampling, processing, and storage on the measurement of complement activation biomarkers","volume":"143","author":"Yang","year":"2015","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.nano.2026.102983_bb0160","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1160\/TH14-04-0300","article-title":"Complement depletion with humanised cobra venom factor: efficacy in preclinical models of vascular diseases","volume":"113","author":"Vogel","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.nano.2026.102983_bb0165","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-2362.1994.tb01092.x","article-title":"Effects of systemic complement activation on renal circulation of rats","volume":"24","author":"Schlottmann","year":"1994","journal-title":"Eur J Clin Investig"},{"issue":"17","key":"10.1016\/j.nano.2026.102983_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/ma14174853","article-title":"Impact of polyethylene glycol functionalization of graphene oxide on anticoagulation and haemolytic properties of human blood","volume":"14","author":"Kamenska","year":"2021","journal-title":"Materials (Basel)"},{"issue":"6","key":"10.1016\/j.nano.2026.102983_bb0175","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/sj.bjp.0706386","article-title":"Nanoparticle-induced platelet aggregation and vascular thrombosis","volume":"146","author":"Radomski","year":"2005","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.nano.2026.102983_bb0180","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/01.RES.70.5.893","article-title":"Putative mechanism of hypotensive action of platelet-activating factor in dogs","volume":"70","author":"Yamanaka","year":"1992","journal-title":"Circ Res"},{"key":"10.1016\/j.nano.2026.102983_bb0185","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0014-2999(88)90226-9","article-title":"Antagonism of the vasodilator effects of a platelet activating factor precursor in anesthetized spontaneously hypertensive rats","volume":"145","author":"Ma","year":"1988","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.nano.2026.102983_bb0190","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.2147\/IJN.S129300","article-title":"Protein corona: a new approach for nanomedicine design","volume":"12","author":"Nguyen","year":"2017","journal-title":"Int J Nanomedicine"},{"issue":"3","key":"10.1016\/j.nano.2026.102983_bb0195","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.tibtech.2016.08.011","article-title":"Biological identity of nanoparticles in vivo: clinical implications of the protein corona","volume":"35","author":"Caracciolo","year":"2017","journal-title":"Trends Biotechnol"},{"issue":"2","key":"10.1016\/j.nano.2026.102983_bb0200","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jconrel.2012.02.029","article-title":"Prevention of infusion reactions to PEGylated liposomal doxorubicin via tachyphylaxis induction by placebo vesicles: a porcine model","volume":"160","author":"Szebeni","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2026.102983_bb0205","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.2147\/IJN.S156528","article-title":"Dextran-coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging: evaluation of size-dependent imaging properties, storage stability and safety","volume":"13","author":"Unterweger","year":"2018","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2026.102983_bb0210","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jconrel.2021.08.048","article-title":"Complement opsonization of nanoparticles: differences between humans and preclinical species","volume":"338","author":"Li","year":"2021","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2026.102983_bb0215","first-page":"97","article-title":"Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity","volume":"10","author":"Lee","year":"2014","journal-title":"Int J Nanomedicine"},{"issue":"21","key":"10.1016\/j.nano.2026.102983_bb0220","doi-asserted-by":"crossref","first-page":"9069","DOI":"10.1021\/acs.nanolett.1c02746","article-title":"Getting to the core of It all: Nanocapsules to mitigate infusion reactions can promote hemostasis and be a platform for intravenous therapies","volume":"21","author":"Maisha","year":"2021","journal-title":"Nano Lett"},{"key":"10.1016\/j.nano.2026.102983_bb0225","article-title":"Antibodies against poly(ethylene glycol) activate innate immune cells and induce hypersensitivity reactions to PEGylated nanomedicines","author":"Chen","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2026.102983_bb0230","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jhazmat.2012.08.003","article-title":"The effect of novel magnetic nanoparticles on vascular endothelial cell function in vitro and in vivo","volume":"235-236","author":"Su","year":"2012","journal-title":"J Hazard Mater"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426000845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426000845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T07:27:49Z","timestamp":1784014069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963426000845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":46,"alternative-id":["S1549963426000845"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2026.102983","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PEGylation-associated hemodynamic effects in a rodent model of acute hypersensitivity reaction: Complement activation-mediated mechanisms","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2026.102983","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102983"}}